http://www.kidney-international.org & 2012 KDIGO
Abbreviations and Acronyms Kidney International Supplements (2012) 2, 5; doi:10.1038/kisup.2012.5
AAMI ACCP ACD-A ACE-I ADQI AHCPR AKD AKI AKIN ANP aPTT ARB ARF ARFTN ATN AUC BMI BUN CDC CHF CI CI-AKI CIT CKD CrCl CRF CRRT CT CVC CVVH CVVHDF eCrCl EGDT eGFR ERT ESRD FDA GFR HDF HES
American Association of Medical Instrumentation American College of Chest Physicians Anticoagulant dextrose solution A Angiotensin-converting enzyme inhibitor(s) Acute Dialysis Quality Initiative Agency for Health Care Policy and Research Acute kidney diseases and disorders Acute kidney injury Acute Kidney Injury Network Atrial natriuretic peptide Activated partial thromboplastin time Angiotensin-receptor blocker(s) Acute renal failure Acute Renal Failure Trial Network Acute tubular necrosis Area under the curve Body mass index Blood urea nitrogen Centers for Disease Control Congestive heart failure Confidence interval Contrast-induced acute kidney injury Conventional insulin therapy Chronic kidney disease Creatinine clearance Chronic renal failure Continuous renal replacement therapy Computed tomography Central venous catheters Continuous venovenous hemofiltration Continuous venovenous hemodiafiltration Estimated creatinine clearance Early goal-directed therapy Estimated glomerular filtration rate Evidence Review Team End-stage renal disease Food and Drug Administration Glomerular filtration rate Hemodiafiltration Hydroxyethylstarch
Kidney International Supplements (2012) 2, 5
HF HIT HR i.a. ICU IGF-1 IHD IIT i.v. KDIGO KDOQI LOS MDRD MI MIC MRI MW NAC NICE-SUGAR
NKD NKF NSF OR PD PICARD RCT RIFLE RR RRT SAFE SCr ScvO2 SLED TCC VISEP
Hemofiltration Heparin-induced thrombocytopenia Hazard ratio Intraarterial Intensive-care unit Insulin-like growth factor-1 Intermittent hemodialysis Intensive insulin therapy Intravenous Kidney Disease: Improving Global Outcomes Kidney Disease Outcomes Quality Initiative Length of stay Modification of Diet in Renal Disease Myocardial infarction Minimum inhibitory concentration Magnetic resonance imaging Molecular weight N-acetylcysteine Normoglycemia in Intensive Care Evaluation and Survival Using Glucose Algorithm Regulation No known kidney disease National Kidney Foundation Nephrogenic Systemic Fibrosis Odds ratio Peritoneal dialysis Program to Improve Care in Acute Renal Disease Randomized controlled trial Risk, Injury, Failure; Loss, End-Stage Renal Disease Relative risk Renal replacement therapy Saline vs. Albumin Fluid Evaluation Serum creatinine Central venous oxygen saturation Sustained low-efficiency dialysis Tunneled cuffed catheter Efficacy of Volume Substitution and Insulin Therapy in Severe Sepsis
5
Abbreviations and Acronyms Kidney International Supplements (2012) 2, 5; doi:10.1038/kisup.2012.5
AAMI ACCP ACD-A ACE-I ADQI AHCPR AKD AKI AKIN ANP aPTT ARB ARF ARFTN ATN AUC BMI BUN CDC CHF CI CI-AKI CIT CKD CrCl CRF CRRT CT CVC CVVH CVVHDF eCrCl EGDT eGFR ERT ESRD FDA GFR HDF HES
American Association of Medical Instrumentation American College of Chest Physicians Anticoagulant dextrose solution A Angiotensin-converting enzyme inhibitor(s) Acute Dialysis Quality Initiative Agency for Health Care Policy and Research Acute kidney diseases and disorders Acute kidney injury Acute Kidney Injury Network Atrial natriuretic peptide Activated partial thromboplastin time Angiotensin-receptor blocker(s) Acute renal failure Acute Renal Failure Trial Network Acute tubular necrosis Area under the curve Body mass index Blood urea nitrogen Centers for Disease Control Congestive heart failure Confidence interval Contrast-induced acute kidney injury Conventional insulin therapy Chronic kidney disease Creatinine clearance Chronic renal failure Continuous renal replacement therapy Computed tomography Central venous catheters Continuous venovenous hemofiltration Continuous venovenous hemodiafiltration Estimated creatinine clearance Early goal-directed therapy Estimated glomerular filtration rate Evidence Review Team End-stage renal disease Food and Drug Administration Glomerular filtration rate Hemodiafiltration Hydroxyethylstarch
Kidney International Supplements (2012) 2, 5
HF HIT HR i.a. ICU IGF-1 IHD IIT i.v. KDIGO KDOQI LOS MDRD MI MIC MRI MW NAC NICE-SUGAR
NKD NKF NSF OR PD PICARD RCT RIFLE RR RRT SAFE SCr ScvO2 SLED TCC VISEP
Hemofiltration Heparin-induced thrombocytopenia Hazard ratio Intraarterial Intensive-care unit Insulin-like growth factor-1 Intermittent hemodialysis Intensive insulin therapy Intravenous Kidney Disease: Improving Global Outcomes Kidney Disease Outcomes Quality Initiative Length of stay Modification of Diet in Renal Disease Myocardial infarction Minimum inhibitory concentration Magnetic resonance imaging Molecular weight N-acetylcysteine Normoglycemia in Intensive Care Evaluation and Survival Using Glucose Algorithm Regulation No known kidney disease National Kidney Foundation Nephrogenic Systemic Fibrosis Odds ratio Peritoneal dialysis Program to Improve Care in Acute Renal Disease Randomized controlled trial Risk, Injury, Failure; Loss, End-Stage Renal Disease Relative risk Renal replacement therapy Saline vs. Albumin Fluid Evaluation Serum creatinine Central venous oxygen saturation Sustained low-efficiency dialysis Tunneled cuffed catheter Efficacy of Volume Substitution and Insulin Therapy in Severe Sepsis
5
